Therapeutic Asset Ratings
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
(+)-VINCRISTINE
Lymphoblastic Lymphoma
University of Washington
P4
BB
(71)
WARFARIN
Cirrhosis Of Liver
Kafrelsheikh University
P4
BB
(71)
WARFARIN
Stroke Disorder
China National Center for Cardiovascular Diseases
P4
BB
(71)
WARFARIN
Transient Ischemic Attack
Seoul National University Hospital
P4
BB
(71)
ZIPRASIDONE
Schizophrenia
Shanghai Mental Health Center
P4
BB
(71)
Abbv-951
Parkinson Disease
AbbVie
P3
BB
(71)
Abiraterone Acetate
Prostate Neoplasm
Qilu Pharmaceutical Co., Ltd.
P3
BB
(71)
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
B-Cell Acute Lymphoblastic Leukemia
City of Hope Medical Center
P3
BB
(71)
Capivasertib
Triple-Negative Breast Carcinoma
AstraZeneca
P3
BB
(71)
Carboplatin
Ovarian Carcinoma
University of Washington
P3
BB
(71)
Carboplatin
Ovarian Neoplasm
Eli Lilly and Company
P3
BB
(71)
CHLORAMBUCIL
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLC
P3
BB
(71)
CIS-DIAMMINEDICHLOROPLATINUM II
Head And Neck Squamous Cell Carcinoma
Akeso
P3
BB
(71)
CIS-DIAMMINEDICHLOROPLATINUM II
Estrogen-Receptor Negative Breast Cancer
University of Washington
P3
BB
(71)
Cyclophosphamide
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(71)
Cyclophosphamide
Gastroesophageal Junction Adenocarcinoma
Beijing Biotech
P3
BB
(71)
Cyclophosphamide
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(71)
Cyclophosphamide
Urothelial Carcinoma
Beijing Biotech
P3
BB
(71)
CYCLOSPORIN A
Chronic Myeloid Leukemia
Fred Hutchinson Cancer Center
P3
BB
(71)
CYCLOSPORIN A
Graft Versus Host Disease
Memorial Sloan Kettering Cancer Center
P3
BB
(71)
Docetaxel
Breast Carcinoma
Dana-Farber Cancer Institute
P3
BB
(71)
DOXORUBICIN
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
BB
(71)
DOXORUBICIN
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)
P3
BB
(71)
DOXORUBICIN
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
BB
(71)
DOXORUBICIN
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)
P3
BB
(71)
Showing 1126 to 1150 of 42,334 assets
Previous
Page 46 of 1694
Next